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The reliability of the McCabe score as a marker of co-morbidity in healthcare-
associated infection point prevalence studies 
JS Reilly, B Coignard, L Price, J Godwin, S Cairns, S Hopkins, O Lyytikäinen,  
S Hansen, W Malcolm, GJ Hughes 
 
Abstract 
This study aimed to ascertain the reliability of the McCabe score in a healthcare-associated 
infection point prevalence survey. A 10 European Union Member States survey in 20 
hospitals (n=1912) indicated that there was a moderate level of agreement (κ =0.57) with the 
score. The reliability of the application of the score could be increased by training data 
collectors, particularly with reference to the ultimately fatal criteria. This is important if the 
score is to be used to risk adjust data to drive infection prevention and control interventions. 
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Introduction 
The classic McCabe-Jackson criteria to predict the likelihood for survival of patients with 
gram-negative bacteraemia on the basis of the level of underlying disease was first developed 
based on observations of endotoxin tolerance in humans (McCabe and Jackson 1962). In 
healthcare-associated infection (HAI) point prevalence survey it is used as a subjective score 
of underlying illness severity.  This simple method of classifying patients according to a 
prognosis of: rapidly fatal (< 1 year), ultimately fatal (1-4 years), and nonfatal (>5 years), has 
been shown to be a better predictor of survival than the APACHE II score (Perl et al 1995). 
More recently it has been demonstrated to be a strong determinant of septic shock related 
mortality (Delodder et al 2011). It has also been modified for use in intensive care units with 
the original three-group classification into a four-group model by splitting the 'ultimately 
fatal' prognosis into a 'long-term' (> 6 months) and a 'short-term' prognosis (< 6 months) 
(Fernandez et al 2006).  
With respect to HAI in the hospital setting it has been shown to correlate with the prevalence 
of HAI in Finland (Lyytikäinen
 
et al 2008) and France
 
(Thiolet et al 2007) and more recently 
in a pilot of the European PPS (Zarb et al 2012), and with specific types of HAI in specific 
settings such as UTI in surgical settings
 
(Medina et al 1997). It is therefore a potentially 
important tool for risk stratification in infection prevention and control. However, little is 
known about the reliability of the measure itself.  
As the McCabe score is seen as a subjective measure of clinical prognosis, the validity and 
reliability of this measure in studies of HAI is important to ascertain. We have previously 
reported on the results of a pilot PPS validation study in Europe
 
(Reilly et al 2015). Here we 
report on the reliability of the recording of the McCabe score in data collected for the 




A validation study of the PPS for HAI was carried out in ten European Union Member States. 
Each contributed data for a minimum of 200 patients from at least two hospitals. The 
McCabe score was collected from information in the medical records or through discussion 
with the medical staff in the ward. 
 
The reference (gold standard), for the validation process was the ECDC-PPS protocol and 
codebook
 
(ECDC 2011) applied by a validation team of at least one trained expert external 
from (and/or acting on behalf of) the national/regional PPS coordinating centre. This expert 
was accompanied by a hospital infection control team member who had undertaken the 
primary PPS data collection, for the purposes of access and orientation. Identical data 
collection was conducted by the validator. Patient notes, nursing notes, hospital information 
systems and clinicians were the data sources.  Ethical approval was obtained from Glasgow 
Caledonian Ethics Committee and approval for data collection was secured by each member 
state to comply with local requirements however no personal identifying information was 
transferred to the authors from the local data collection teams”. 
 
Concordance between the validator and primary collectors were analysed using the kappa 
statistic (κ). The record matching and subsequent analyses were performed using bespoke 
software written ab initio in FORTRAN 95 and run under OpenVMS on a Compaq Alpha 
system. Interpretation of κ was (κ: 0.81-1.00 is excellent, 0.61-0.80 is good, 0.41-0.60 is 
moderate, 0.21-0.40 is fair/marginal, <0.2 is poor agreement; negative values are possible and 




Of the 3,958 patient records, a total of 1,950 were selected for validation in accordance with 
the calculated study sample size. Of those, 1,912 were matched to the primary dataset, since 
it was not possible to link all patient records due to errors in data entry or missing data. 
 
McCabe scores were recorded in both the primary and validation datasets in 1526/1912 
(79.8%) of all recorded data. For the remainder around 16.7% were unknown, due to lack of 
information in the medical records or the clinician not being available to calculate the score, 
either by the primary data collector and/or the validation data collector and 3.5% were 
unmatched (primary/ validation) data. There was minimal variation in McCabe completion by 
European Union Member State. Table 1 presents the data by category of McCabe score. The 
McCabe score had moderate levels of agreement in the dataset where all responses were 

















Non fatal Rapidly Fatal 
(within 1 year) 
Ultimately fatal 
(within 5 years) 
Unknown Total 
Non fatal 961 (94%) 9 (8%) 49(13%) 194 1213 
Rapidly Fatal 8(1%) 81(72%) 19 (5%) 2 110 
Ultimately 
fatal 
56(5%) 23(20%) 320 (82%) 15 414 
Unknown 60 1 29 19 109 





 66 not matched  
 
Where the McCabe score was either classified by the data collector or provided by the 
clinician (n=1526), the levels of agreement between the primary data collector and validator 
were: 94% (961/1025) for non fatal, 72% (81/113) for rapidly fatal, 82% (320/388) for 
ultimately fatal (Table 1). The McCabe score had good agreement in the dataset when 






The McCabe score is a useful predictor of risk for infection in selected settings in published 
studies (Perl et al 1995; Medina et al 1997; Fernandez et al 2006; Thiolet et al 2007; 
Lyytikäinen
 et
 al 2008; Delodder et al 2011; Zarb et al 2012). However, this study is the first 
to formally assess its reliability in an HAI prevalence study in the hospital setting. The results 
show a moderate level of agreement overall when all data were taken account of, inclusive of 
unknowns by either the primary or validation data collector (κ 0.57).  
Variation in agreement was noted by category of McCabe. Rapidly fatal had poorer levels of 
agreement (72%) than other categories, whereas non-fatal had high levels of agreement 
(94%). This variation indicates that some of the categories of McCabe may be easier to 
interpret than others and suggests that data collectors, perhaps especially if they are not 
clinicians, may have difficulties in assessing a patient’s short-term prognosis. Importantly, 
the McCabe score had good level of agreement in the dataset where both primary and 
validator data collectors had recorded the result (κ = 0.78). 
The McCabe score requires abstractor judgement, usually involving verification with a 
clinician present on the ward. This means that data collectors may record ‘unknown’ when 
they are unsure of the score or unable to find the information required to calculate the score. 
These results indicate that investment in training of data collectors in the McCabe 
classification would be worthwhile to maximise data completion and enhance the reliability 
of the data. Reliable recording of this score will enable risk adjustment for infection 
prevention and control assessment. 




Delodder F Que YA Revelly JP Eggimann P (2011) McCabe score as a strong determinant of 
septic shock-related mortality. Biomedcentral proceedings 5(Suppl 6): 74 
 
European Centre for Disease Prevention and Control (2011) Point prevalence survey of 
healthcare-associated infections and antimicrobial use in European acute care hospitals  
Protocol version 4.2. Stockholm, Sweden.  
Fernandez R  Baigorri F Navarro G  Artigas A (2006)  A modified McCabe score for 
stratification of patients after intensive care unit discharge: the Sabadell score. Critical Care 
10: R179.  
Lyytikäinen O Kanerva M Agthe N Möttönen T, Ruutu P (2008)  Finnish Prevalence Survey 
Study Group. Healthcare-associated infections in Finnish acute care hospitals: a national 
prevalence survey 2005. Journal of Hospital Infection 69 (3): 288-94 
Medina MMartínez-GallegoG Sillero-Arenas M  Delgado-Rodríguez M (1997) Risk factors 
and length of stay attributable to hospital infections of the urinary tract in general surgery 
patients. Enfermedades Infecciosas y Microbiología Clínica  15 (6) :310-4 
 
McCabe WR and Jackson GG (1962) Gram-negative bacteremia. I. Etiology and ecology. 
Archives Internal Medicine 110(6): 847-53. 
 
PerlTM Dvorak L Hwang TWenzel RP (1995) Long-term survival and function after 
suspected gram-negative bacteremia. Journal American Medical Association 274 (4): 338-45. 
Reilly JS Price L Godwin J Cairns S Hopkins S Cookson B Malcolm W Hughes G 
Lyytikaïnen O Coignard , Hansen , Suetens C (2015) National Participants in the ECDC pilot 
 8 
validation study. A pilot validation in 10 European Union Member States of a point 
prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals 
in Europe, 2011. Eurosurveilancel 20(8): pii=21045 
Thiolet JM Lacavé L Jarno P Metzger MH Tronel H Gautier C L’Heriteau F Coignard 
B(2007) Prévalence des infections nosocomiales France 2006. Bulletin épidémiologique 
hebdomadaire ; 51-52: 429-32   
Zarb P Coignard B Griskeviciene J Muller A Vankerckhoven V Weist K Goossens MM Vaerenberg S 
Hopkins S Catry B Monnet DL Goossens H Suetens C   (2012) The European Centre for Disease 
Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated 
infections and antimicrobial use. Eurosurveillance ;17(46):20316 
